{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T21:55:32Z","timestamp":1775339732532,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.chest.2016.07.030","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T06:38:50Z","timestamp":1470897530000},"page":"1361-1370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Translational Research in Pleural Infection and Beyond"],"prefix":"10.1016","volume":"150","author":[{"given":"Y. C. Gary","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Idell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios T.","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2016.07.030_bib1","series-title":"Textbook of Pleural Diseases","first-page":"1","article-title":"Pleural diseases: historic perspectives","author":"Tassi","year":"2016"},{"key":"10.1016\/j.chest.2016.07.030_bib2","first-page":"59","article-title":"A\u00a0case of empyema: notes on the last illness of Sir William Osler","volume":"86","author":"Barondess","year":"1975","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3201\/eid1501.080618","article-title":"Parapneumonic empyema deaths during past century","volume":"15","author":"Bender","year":"2009","journal-title":"Utah. Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1440-1843.2011.01964.x","article-title":"Pleural infection: changing bacteriology and its implications","volume":"16","author":"Lisboa","year":"2011","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.chest.2016.07.030_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/thx.2010.156406","article-title":"The emergence of parapneumonic empyema in the United States","volume":"66","author":"Grijalva","year":"2011","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.chest.2016.07.030_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa042473","article-title":"U.K. Controlled trial of intrapleural streptokinase for pleural infection","volume":"352","author":"Maskell","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib8","first-page":"999","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection","volume":"7","author":"Piccolo","year":"2015","journal-title":"J\u00a0Thorac Dis"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib9","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1378\/chest.117.6.1728","article-title":"Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus","volume":"117","author":"Simpson","year":"2000","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MCP.0b013e328352c673","article-title":"Pleural infection: what we need to know but don\u2019t","volume":"18","author":"Tobin","year":"2012","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0033-1334486","article-title":"Plasminogen-plasmin system in the pathogenesis and treatment of lung and pleural injury","volume":"39","author":"Tucker","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MCP.0b013e3282fd0d9b","article-title":"The pathogenesis of pleural space loculation and fibrosis","volume":"14","author":"Idell","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.chest.2016.07.030_bib13","first-page":"275","article-title":"The use of streptokinase-streptodornase in the treatment of post[p]neumonic empyema","volume":"21","author":"Tillett","year":"1951","journal-title":"J\u00a0Thorac Surg"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1172\/JCI102046","article-title":"The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations","volume":"28","author":"Tillett","year":"1949","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1164\/rccm.2404013","article-title":"Ongoing search for effective intrapleural therapy for empyema","volume":"170","author":"Lee","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200312-1740OC","article-title":"Intrapleural streptokinase for empyema and complicated parapneumonic effusions","volume":"170","author":"Diacon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1378\/chest.129.6.1577","article-title":"Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model","volume":"129","author":"Zhu","year":"2006","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.chest.2016.07.030_bib18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1513\/AnnalsATS.201407-329OC","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection: an effective and safe alternative to surgery","volume":"11","author":"Piccolo","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chest.2016.07.030_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000443334","article-title":"Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease","volume":"91","author":"Mehta","year":"2016","journal-title":"Respiration"},{"issue":"9","key":"10.1016\/j.chest.2016.07.030_bib20","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1513\/AnnalsATS.201602-127OC","article-title":"Concurrent intrapleural instillation of tissue plasminogen activator and deoxyribonuclease for pleural infection: a single center experience","volume":"13","author":"Majid","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.chest.2016.07.030_bib21","first-page":"A4313","volume":"187","author":"Komissarov","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/ajrccm\/144.1.187","article-title":"Abnormalities of pathways of fibrin turnover in the human pleural space","volume":"144","author":"Idell","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib23","doi-asserted-by":"crossref","first-page":"L568","DOI":"10.1152\/ajplung.00066.2009","article-title":"Regulation of intrapleural fibrinolysis by urokinase-\u03b1-macroglobulin complexes in tetracycline-induced pleural injury in rabbits","volume":"297","author":"Komissarov","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"8","key":"10.1016\/j.chest.2016.07.030_bib24","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1183\/09031936.95.08081352","article-title":"Fibrinolytic and inflammatory processes in pleural effusions","volume":"8","author":"Philip-Joet","year":"1995","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2016.07.030_bib25","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0012-3692(15)50413-3","article-title":"Proinflammatory cytokines, transforming growth factor-\u03b21, and fibrinolytic enzymes in\u00a0loculated and free-flowing pleural exudates","volume":"128","author":"Chung","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1165\/rcmb.2012-0183OC","article-title":"Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits","volume":"48","author":"Karandashova","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"10.1016\/j.chest.2016.07.030_bib27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1164\/rccm.200605-644OC","article-title":"4G\/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia","volume":"176","author":"Yende","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1165\/rcmb.2014-0168OC","article-title":"Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits","volume":"52","author":"Florova","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12032-015-0612-0","article-title":"The palliative treatment with intrapleural streptokinase in patients with multiloculated malignant pleural effusion: a double-blind, placebo-controlled, randomized study","volume":"32","author":"Saydam","year":"2015","journal-title":"Med Oncol"},{"issue":"5","key":"10.1016\/j.chest.2016.07.030_bib30","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1378\/chest.126.5.1636","article-title":"Intrapleural injection of transforming growth factor-\u03b2 antibody inhibits pleural fibrosis in empyema","volume":"126","author":"Kunz","year":"2004","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2016.07.030_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1378\/chest.111.2.275","article-title":"Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions","volume":"111","author":"Chin","year":"1997","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2214\/ajr.160.1.8416618","article-title":"Fluid flow during percutaneous drainage procedures: an in\u00a0vitro study of the effects of fluid viscosity, catheter size, and adjunctive urokinase","volume":"160","author":"Park","year":"1993","journal-title":"AJR Am J Roentgenol"},{"issue":"49","key":"10.1016\/j.chest.2016.07.030_bib33","doi-asserted-by":"crossref","first-page":"41949","DOI":"10.1074\/jbc.M111.301218","article-title":"Effects of extracellular DNA on plasminogen activation and fibrinolysis","volume":"286","author":"Komissarov","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1165\/rcmb.2014-0017OC","article-title":"Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism","volume":"53","author":"Lansley","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.chest.2016.07.030_bib35","doi-asserted-by":"crossref","first-page":"e0119238","DOI":"10.1371\/journal.pone.0119238","article-title":"Preclinical assessment of adjunctive tPA and DNase for peritoneal dialysis associated peritonitis","volume":"10","author":"McGuire","year":"2015","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.chest.2016.07.030_bib36","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1056\/ENEJMicm020531","article-title":"Images in clinical medicine: effect of intrapleural streptokinase on a loculated malignant pleural effusion","volume":"348","author":"Maskell","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2016.07.030_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM200508183530722","article-title":"Response of a nonmalignant pleural effusion to bevacizumab","volume":"353","author":"Pichelmayer","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib38","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cllc.2013.06.007","article-title":"Structural basis\u00a0for hyperpermeability of tumor vessels in advanced lung adenocarcinoma complicated by pleural effusion","volume":"14","author":"Damianovich","year":"2013","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.chest.2016.07.030_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.rmed.2006.05.018","article-title":"Vascular endothelial growth factor levels in post-CABG pleural effusions are associated with pleural inflammation and permeability","volume":"101","author":"Kalomenidis","year":"2007","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib40","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1378\/chest.127.6.2094","article-title":"Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions","volume":"127","author":"Kalomenidis","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0015-0282(97)81383-0","article-title":"Markedly elevated cytokines in pleural effusion during the ovarian hyperstimulation syndrome: transudate or ascites?","volume":"67","author":"Loret de Mola","year":"1997","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib42","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1183\/09031936.00182308","article-title":"Etanercept-induced pleuropericardial lupus-like syndrome","volume":"33","author":"Porfyridis","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF01534438","article-title":"Modulation of endothelial cell permeability by lung carcinoma cells: a potential mechanism of malignant pleural effusion formation","volume":"18","author":"Payne","year":"1994","journal-title":"Inflammation"},{"issue":"1-2","key":"10.1016\/j.chest.2016.07.030_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1024942132705","article-title":"Pulmonary edema and pleural effusion in norepinephrine-stimulated rats: hemodynamic or inflammatory effect?","volume":"250","author":"Rassler","year":"2003","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"10.1016\/j.chest.2016.07.030_bib45","doi-asserted-by":"crossref","first-page":"e75287","DOI":"10.1371\/journal.pone.0075287","article-title":"Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma","volume":"8","author":"Yeh","year":"2013","journal-title":"PLoS One"},{"issue":"31","key":"10.1016\/j.chest.2016.07.030_bib46","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/sj.onc.1209464","article-title":"Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion","volume":"25","author":"Yeh","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.chest.2016.07.030_bib47","first-page":"3364","article-title":"Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions","volume":"5","author":"Zebrowski","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.chest.2016.07.030_bib48","first-page":"957","article-title":"Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation","volume":"6","author":"Yano","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib49","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0002-9440(10)64828-6","article-title":"Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor\/vascular permeability factor by human lung cancer cells","volume":"157","author":"Yano","year":"2000","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/rccm.201203-0465PP","article-title":"Malignant pleural effusion: tumor-host interactions unleashed","volume":"186","author":"Stathopoulos","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"20","key":"10.1016\/j.chest.2016.07.030_bib51","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1158\/0008-5472.CAN-07-1064","article-title":"Tumor necrosis factor-\u03b1 promotes malignant pleural effusion","volume":"67","author":"Stathopoulos","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1164\/rccm.200710-1513OC","article-title":"Zoledronic acid is effective against experimental malignant pleural effusion","volume":"178","author":"Stathopoulos","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1440-1843.2007.01153.x","article-title":"Pneumothorax-associated pleural eosinophilia is tumour necrosis factor-\u03b1-dependent and attenuated by steroids","volume":"13","author":"Kalomenidis","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.chest.2016.07.030_bib54","doi-asserted-by":"crossref","first-page":"e29195","DOI":"10.4161\/onci.29195","article-title":"Monoclonal antibody targeting of mononuclear cell chemokines driving malignant pleural effusion","volume":"3","author":"Marazioti","year":"2014","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.chest.2016.07.030_bib55","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00432-009-0555-y","article-title":"Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion","volume":"135","author":"Fang","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.200804-616ED","article-title":"Malignant pleural effusions: fixing the leaky faucet","volume":"178","author":"Lee","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2016.07.030_bib57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2169\/internalmedicine1962.26.319","article-title":"Dynamics of pleural effusion estimated through urea clearance","volume":"26","author":"Nakamura","year":"1987","journal-title":"Jpn J Med"},{"issue":"5","key":"10.1016\/j.chest.2016.07.030_bib58","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1440-1843.2009.01536.x","article-title":"Osteopontin is upregulated in malignant and inflammatory pleural effusions","volume":"14","author":"Moschos","year":"2009","journal-title":"Respirology"},{"issue":"12","key":"10.1016\/j.chest.2016.07.030_bib59","doi-asserted-by":"crossref","first-page":"L1265","DOI":"10.1152\/ajplung.00396.2014","article-title":"Mesomesenchymal transition of pleural mesothelial cells is PI3K and NF-\u03baB dependent","volume":"308","author":"Owens","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1165\/rcmb.2014-0084OC","article-title":"Thrombin down-regulates tissue factor pathway inhibitor expression in a PI3K\/nuclear factor-\u03baB-dependent manner in human pleural mesothelial cells","volume":"52","author":"Jeffers","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.chest.2016.07.030_bib61","first-page":"389","article-title":"Asbestos causes translocation of p65 protein and increases NF-\u03baB DNA binding activity in rat lung epithelial and pleural mesothelial cells","volume":"151","author":"Janssen","year":"1997","journal-title":"Am J Pathol"},{"issue":"24","key":"10.1016\/j.chest.2016.07.030_bib62","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/onc.2010.643","article-title":"Onconase mediated NFK\u03b2 downregulation in malignant pleural mesothelioma","volume":"30","author":"Goparaju","year":"2011","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.chest.2016.07.030_bib63","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s10753-014-9994-y","article-title":"Naringin attenuates the development of carrageenan-induced acute lung inflammation through inhibition of NF-\u03baB, STAT3 and pro-inflammatory mediators and enhancement of I\u03baB\u03b1 and anti-inflammatory cytokines","volume":"38","author":"Ahmad","year":"2015","journal-title":"Inflammation"},{"issue":"7","key":"10.1016\/j.chest.2016.07.030_bib64","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/PL00000213","article-title":"Synergistic antiinflammatory effect of NF-\u03baB inhibitors and steroidal or non steroidal antiinflammatory drugs in the pleural inflammation induced by carrageenan in mice","volume":"49","author":"Frode-Saleh","year":"2000","journal-title":"Inflamm Res"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib65","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bcp.2009.04.030","article-title":"Cyclic AMP enhances resolution of allergic pleurisy by promoting inflammatory cell apoptosis via inhibition of PI3K\/Akt and NF-\u03baB","volume":"78","author":"Sousa","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-065X.2011.01091.x","article-title":"Dimer-specific regulatory mechanisms within the NF-\u03baB family of transcription factors","volume":"246","author":"Smale","year":"2012","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.chest.2016.07.030_bib67","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni.2070","article-title":"Hierarchies of NF-\u03baB target-gene regulation","volume":"12","author":"Smale","year":"2011","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.chest.2016.07.030_bib68","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/onc.2012.57","article-title":"Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion","volume":"32","author":"Psallidas","year":"2013","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.chest.2016.07.030_bib69","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/jnci\/djn325","article-title":"A\u00a0central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion","volume":"100","author":"Stathopoulos","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib70","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1172\/JCI79840","article-title":"Mast cells mediate malignant pleural effusion formation","volume":"125","author":"Giannou","year":"2015","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.chest.2016.07.030_bib71","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201001-0001OC","article-title":"Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion","volume":"182","author":"Stathopoulos","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2016.07.030_bib72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-4598-9-56","article-title":"Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study","volume":"9","author":"Psallidas","year":"2010","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.chest.2016.07.030_bib73","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1165\/rcmb.2005-0130OC","article-title":"Nuclear factor-\u03baB affects tumor progression in a mouse model of malignant pleural effusion","volume":"34","author":"Stathopoulos","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.chest.2016.07.030_bib74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2011.09.006","article-title":"Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer","volume":"76","author":"Besse","year":"2012","journal-title":"Lung Cancer"},{"issue":"31","key":"10.1016\/j.chest.2016.07.030_bib75","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1200\/JCO.2006.06.1853","article-title":"Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer","volume":"24","author":"Fanucchi","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.chest.2016.07.030_bib76","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1172\/JCI75661","article-title":"Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth","volume":"124","author":"Barbie","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.chest.2016.07.030_bib77","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nri2163","article-title":"IDO and regulatory T\u00a0cells: a role for reverse signalling and non-canonical NF-\u03baB activation","volume":"7","author":"Puccetti","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.chest.2016.07.030_bib78","doi-asserted-by":"crossref","first-page":"e71207","DOI":"10.1371\/journal.pone.0071207","article-title":"Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion","volume":"8","author":"Marazioti","year":"2013","journal-title":"PLoS One"},{"issue":"3-4","key":"10.1016\/j.chest.2016.07.030_bib79","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/HAB-2007-163-406","article-title":"Generation, characterization and biological activity of CCL2 (MCP-1\/JE) and CCL12 (MCP-5) specific antibodies","volume":"16","author":"Tsui","year":"2007","journal-title":"Hum Antibodies"},{"issue":"7355","key":"10.1016\/j.chest.2016.07.030_bib80","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.chest.2016.07.030_bib81","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1158\/1535-7163.MCT-07-2251","article-title":"Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation","volume":"7","author":"Mason","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/j.chest.2016.07.030_bib82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-007-9865-4","article-title":"The thrombin inhibitor argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms","volume":"112","author":"Schulze","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"10.1016\/j.chest.2016.07.030_bib83","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/onc.2013.184","article-title":"Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via \u03b19\u03b21 integrin","volume":"33","author":"Kale","year":"2014","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.chest.2016.07.030_bib84","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/14728222.2014.925447","article-title":"Osteopontin as a therapeutic target for cancer","volume":"18","author":"Bandopadhyay","year":"2014","journal-title":"Expert Opin Ther Targets"},{"issue":"24","key":"10.1016\/j.chest.2016.07.030_bib85","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1158\/0008-5472.CAN-10-1470","article-title":"p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression","volume":"70","author":"Kumar","year":"2010","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib86","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1164\/rccm.201401-0140ED","article-title":"The lymphatic system in malignant pleural effusion: drain or immune switch?","volume":"189","author":"Marazioti","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2016.07.030_bib87","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1164\/rccm.201310-1776OC","article-title":"Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion","volume":"189","author":"Lin","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2016.07.030_bib88","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201207-1307OC","article-title":"Differentiation and immune regulation of IL-9-producing CD4+ T\u00a0cells in malignant pleural effusion","volume":"186","author":"Ye","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2016.07.030_bib89","series-title":"Sir William Osler: Aphorisms From His Bedside Teachings and Writings","year":"1950"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216536708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216536708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:30:43Z","timestamp":1757921443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216536708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0012369216536708"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2016.07.030","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational Research in Pleural Infection and Beyond","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2016.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}